On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Bioversys AG's own share of each project, not the project's full budget.
- Horizon 2020€7.5M · 3 projects
- FP7 (2007 to 2013)€262k · 1 project
Projects
4 EU-funded projects, newest first. Bioversys AG led 1 of them as coordinator. Each links to the official record.
- TRIC-TBCoordinator
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€6.9Mtheir share - RespiriNTMPartner
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline
Horizon 2020 · 2019–2027 · Project on CORDIS ↗
€280ktheir share - Train2TargetPartner
An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
€265ktheir share - TRANSLOCATIONPartner
MOLECULAR BASIS OF ANTIBIOTIC TRANSLOCATION
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€262ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- University of Newcastle Upon TyneUnited Kingdom · 2 shared projects
- Universitat BaselSwitzerland · 2 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
- Kobenhavns UniversitetDenmark · 1 shared project
- Danmarks Tekniske UniversitetDenmark · 1 shared project
- Universiteit van AmsterdamNetherlands · 1 shared project
- Universiteit LeidenNetherlands · 1 shared project
- The University of BirminghamUnited Kingdom · 1 shared project
- Universiteit AntwerpenBelgium · 1 shared project
- Universite Catholique de LouvainBelgium · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- Universita Degli Studi di MilanoItaly · 1 shared project
- Johann Wolfgang Goethe-Universitaet Frankfurt am MainGermany · 1 shared project
- Medizinische Universitaet WienAustria · 1 shared project
- Sorbonne UniversiteFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotic resistance
- antibiotics
- bacteriology
- drug discovery
- multidrug resistance
- nanotechnology
- surgery
- tuberculosis
Bioversys AG is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
